Clinicopath Conf
Demyelinating Process Consistent with Multiple Sclerosis, Case 26-1998, NEJM 339:542-549998., , 1998
Intraspinal Steroid Therapy
Neurol 31:168-171, Bernat,J.L., 1981
Bladder Dysfunction in Multiple Sclerosis
BMJ 1:1265-1269, Miller,H.,et al, 1965
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004
The Phenotypic Spectrum of CADASIL:Clinical Findings in 102 Cases,
Ann Neurol 44:731-739,715, Dichgans,M.,et al, 1998
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
Tolterodine for Overactive Bladder
The Medical Letter 40:101-102, , 1998
Treatment of Refractory Urge Urinary Incontinence with Sacral Spinal Nerve Stimulation in Multiple Sclerosis Patients
Lancet 348:717-719, Bosch,J.L.&Broen,J., 1996
DDAVP in the Management of Nocturia in Multiple Sclerosis
Ann Neurol 31:577, Valiquette,G.,et al, 1992
Demyelinating Diseases
In Rowlands Merritt's Textbk of Neurology, Lea & Febiger, Phila, 8th Ed, p. 749, Sibley,W.A.,et al, 1989
Dorsal Column Stimulation in Multiple Sclerosis:Effects on Bladder & Long Term Findings
BMJ 287:793-795, Hawkes,C.H.,et al, 1983
Stimulation of Dorsal Column in Multiple Sclerosis
BMJ 280:889-891, Hawkes,C.H.,et al, 1980
Neurologic Disorders Affecting the Urinary Bladder, in Clinical Neuro-Urology
(Ed) , Little, Brown & Co, 1979, pp. 245., Krane,R.J., 1979